Log In
BCIQ
Print this Print this
 

BAX 817

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionRecombinant Factor VIIa (rFVIIa)
Molecular Target Factor VIIa
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationHemophilia
Indication DetailsTreat hemophilia A or B; Treat hemophilia in pediatric patients
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today